— Know what they know.
Not Investment Advice

SRBCF OTC

Sirona Biochem Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -57.9% 3Y: -97.1% 5Y: -90.4%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $1.6M mcap · 245M float · 0.0000% daily turnover · Short 7% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.6M
52W Range0.0001-0.0121
Volume50,000
Avg Volume15
Beta-0.07
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOHoward J. Verrico
Employees10
SectorHealthcare
IndustryBiotechnology
IPO Date2013-02-12
595 Burrard Street
Vancouver, BC V7X 1L4
CA
604 641 4466
About Sirona Biochem Corp.

Sirona Biochem Corp. operates as a biotechnology company dedicated to uncovering and commercializing active ingredients for both cosmetic and pharmaceutical uses, with a commercial presence in Canada and France. Key initiatives include the development of a cosmetic skin brightener and a pharmaceutical solution for diabetes. Beyond these, the company is engaged in several other projects, such as building a library of anti-aging and cell-protective compounds, creating a novel anti-wrinkle agent, and pursuing an antiviral research program. A notable collaboration exists with the International Centre for Genetic Engineering and Biotechnology (ICGEB) for the joint development of an antiviral compound library. Established in 2006, the business, originally named High Rider Capital Inc., rebranded as Sirona Biochem Corp. in May 2009 and maintains its headquarters in Vancouver, Canada.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms